A Phase II Study of Fotemustine Plus Dacarbazine with Dendritic Cell Vaccines as First-Line Therapy for Chinese Patients with Advanced Acral Lentiginous Melanoma
Chinese Patients、Dendritic Cell、evaluation criteria、antitumor activity、complete response、overall survival、liver metastasis、alkylating agent、dendritic cell、response rate
21
R739.5(肿瘤学)
2009-04-03(万方平台首次上网日期,不代表论文的发表时间)
共7页
13-19